跳至主要内容
ProhibitedBinding ruleCNOfficial English translation已检查官方来源导入

抗感染类药物,包括但不限于三溴沙 仑、抗生素类、二氢速甾醇、乙硫异烟 胺、呋喃唑酮、酮康唑、甲硝唑、呋喃 妥因、磺胺类药物(磺胺和其氨基的一 个或多个氢原子被取代的衍生物)及其 盐类、甲巯咪唑、短杆菌素等 — Anti-infectives, including but not limited to 3,4',5-Tribromosalicylanilide (Tribromsalan (INN) )(CAS No. 87-10-5), Antibiotics, Dihydrotachysterol (INN) (CAS No. 67-96-9), Ethionamide (INN) (CAS No. 536-33-4), Furazolidone (INN) (CAS No. 67-45-8), Ketoconazole (CAS No. 65277-42-1), Metronidazole (CAS No. 443-48-1), Nitrofurantoin (INN) (CAS No. 67-20-9), Sulphonamides (sulphanilamide and its derivatives obtained by substitution of one or more H-atoms of the -NH2 groups) and their salts, Thiamazole (INN) (CAS No. 60-56-0), Thyrothricine (CAS No. 1404-88-2)

Anti-infectives, including but not limited to 3,4',5-Tribromosalicylanilide (Tribromsalan (INN) )(CAS No. 87-10-5), Antibiotics, Dihydrotachysterol (INN) (CAS No. 67-96-9), Ethionamide (INN) (CAS No. 536-33-4), Furazolidone (INN) (CAS No. 67-45-8), Ketoco

The NMPA binding 2021 catalogue prohibits this raw material in cosmetic formulas in China.

监管决定及完整条件

状态
Prohibited
法律地位
Binding rule
监管摘要
The NMPA binding 2021 catalogue prohibits this raw material in cosmetic formulas in China.
条件与限制

Prohibited in cosmetic product formulas. Verify the cited Chinese source identity and any later NMPA amendment before use.

物质身份

官方来源名称
抗感染类药物,包括但不限于三溴沙 仑、抗生素类、二氢速甾醇、乙硫异烟 胺、呋喃唑酮、酮康唑、甲硝唑、呋喃 妥因、磺胺类药物(磺胺和其氨基的一 个或多个氢原子被取代的衍生物)及其 盐类、甲巯咪唑、短杆菌素等 — Anti-infectives, including but not limited to 3,4',5-Tribromosalicylanilide (Tribromsalan (INN) )(CAS No. 87-10-5), Antibiotics, Dihydrotachysterol (INN) (CAS No. 67-96-9), Ethionamide (INN) (CAS No. 536-33-4), Furazolidone (INN) (CAS No. 67-45-8), Ketoconazole (CAS No. 65277-42-1), Metronidazole (CAS No. 443-48-1), Nitrofurantoin (INN) (CAS No. 67-20-9), Sulphonamides (sulphanilamide and its derivatives obtained by substitution of one or more H-atoms of the -NH2 groups) and their salts, Thiamazole (INN) (CAS No. 60-56-0), Thyrothricine (CAS No. 1404-88-2)
CAS
87-10-5; 67-96-9; 536-33-4; 67-45-8; 65277-42-1; 443-48-1; 67-20-9; 60-56-0; 1404-88-2
EC
Not supplied in this source row
身份映射
Exact CAS: 65277-42-1
关联成分
KETOCONAZOLE

关联的 CosIng 身份数据

名称和别名

KETOCONAZOLE

CosIng 描述: Ketoconazole is the heterocyclic compound that conforms to the formula

欧盟清单限制备注: II/1528

已记录的化妆品功能: NOT REPORTED

功能页面:NOT REPORTED

查看完整的成分档案

该身份的跨市场概览

本站目前已有的精确关联记录。某市场缺失表示没有已导入的精确匹配,并不表示准许使用该物质。

10 个市场数据集
CAS 1404-88-2 的 PubChem 二维化学结构
CAS 1404-88-2PubChem CID 452550

CAS 1404-88-2 的已核实化学信息

Tyrothricin

Tyrothricin is an antibiotic peptide complex produced and extracted from the aerobic Gram-positive bacillus Brevibacillus parabrevis which was previously categorized as Bacillus brevis and Bacillus aneurinolyticus. This complex is a mixture comprised of 60% tyrocidine cationic cyclic decapeptides (consisting largely of the six predominant tyrocidines, TrcA/A1, TrcB/B1, TrcC/C1, and other more minor contributors) and 40% neutral linear gramicidins (where valine-gramicidin A is often the major gramicidin present, although the mixture composition can vary). Moreover, tyrothricin possesses broad spectrum Gram-positive antibacterial and antifungal activity that has not seen many - if any - significant reportings of microbial resistance during the over 60 years of therapeutic use the complex has provided. Nevertheless, as tyrothricin is both cytolytic and hemolytic, it does demonstrate systemic toxicity, although certain formulations that are safe for human use like throat lozenges do exist. — DrugBank

IUPAC 名称
3-[(3R,6S,9S,12S,15S,17S,20S,22R,25S,28S)-20-(2-amino-2-oxoethyl)-9-(3-aminopropyl)-3,22,25-tribenzyl-15-[(4-hydroxyphenyl)methyl]-6-(2-methylpropyl)-2,5,8,11,14,18,21,24,27-nonaoxo-12-propan-2-yl-1,4,7,10,13,16,19,23,26-nonazabicyclo[26.3.0]hentriacontan-17-yl]propanoic acid
分子式
C65H85N11O13
分子量
1228.4 g/mol
精确质量
1227.63283181 Da
单同位素质量
1227.63283181 Da
XLogP3
1.9
拓扑极性表面积
380.0 Ų
分子复杂度
2390.0
形式电荷
0
氢键供体
12
氢键受体
15
可旋转键
19
重原子
89
共价单元
1

向 PubChem 报告的名称和同义词

BactratycinColtirotDermotricineHydrotricineMartricinTirotricinaTyrothricineSolutricine
另有 16 个已报告名称
TyrothricinumTyrodermTyrosurDubos crude crystalsTyri 10NSC-757363RefChem:192767D06AX08R02AB02S01AA05215-771-0PharothricettenBiothricinGinotricinaRinotricinaTriciderm
外部数据库标识符
高级结构统计
已定义的原子立体中心
10
未定义的原子立体中心
0
已定义的键立体中心
0
未定义的键立体中心
0
三维构象异构体
0
机器可读的结构标识符
SMILES
CC(C)C[C@H]1C(=O)N[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@H](C(=O)N[C@@H](C(=O)[C@@H](NC(=O)[C@@H](N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N1)CCCN)C(C)C)CC3=CC=C(C=C3)O)CCC(=O)O)CC(=O)N)CC4=CC=CC=C4)CC5=CC=CC=C5)CC6=CC=CC=C6
InChI
InChI=1S/C65H85N11O13/c1-38(2)32-49-60(84)74-52(36-42-20-12-7-13-21-42)65(89)76-31-15-23-53(76)63(87)73-51(34-41-18-10-6-11-19-41)61(85)70-47(33-40-16-8-5-9-17-40)57(81)48(37-54(67)78)71-59(83)46(28-29-55(79)80)68-50(35-43-24-26-44(77)27-25-43)62(86)75-56(39(3)4)64(88)69-45(22-14-30-66)58(82)72-49/h5-13,16-21,24-27,38-39,45-53,56,68,77H,14-15,22-23,28-37,66H2,1-4H3,(H2,67,78)(H,69,88)(H,70,85)(H,71,83)(H,72,82)(H,73,87)(H,74,84)(H,75,86)(H,79,80)/t45-,46-,47+,48-,49-,50-,51-,52+,53-,56-/m0/s1
InChIKey
NLJVXZFCYKWXLH-DXTIXLATSA-N

于 2026-09-02 通过校验和有效的 CAS 匹配从美国国立卫生研究院 (NIH) PubChem 检索。化学性质不能取代本页的监管决定。

CAS 443-48-1 的 PubChem 二维化学结构
CAS 443-48-1PubChem CID 4173

CAS 443-48-1 的已核实化学信息

Metronidazole

Metronidazole is a member of the class of imidazoles substituted at C-1, -2 and -5 with 2-hydroxyethyl, nitro and methyl groups respectively. It has activity against anaerobic bacteria and protozoa, and has a radiosensitising effect on hypoxic tumour cells. It may be given by mouth in tablets, or as the benzoate in an oral suspension. The hydrochloride salt can be used in intravenous infusions. Metronidazole is a prodrug and is selective for anaerobic bacteria due to their ability to intracellularly reduce the nitro group of metronidazole to give nitroso-containing intermediates. These can covalently bind to DNA, disrupting its helical structure, inducing DNA strand breaks and inhibiting bacterial nucleic acid synthesis, ultimately resulting in bacterial cell death. It has a role as a radiosensitizing agent, an antiamoebic agent, an antimicrobial agent, an antiparasitic agent, a xenobiotic, an antibacterial drug, a prodrug, an antitrichomonal drug and an environmental contaminant. It is a primary alcohol, a member of imidazoles and a C-nitro compound. It is a conjugate base of a metronidazole(1+). — ChEBI

IUPAC 名称
2-(2-methyl-5-nitroimidazol-1-yl)ethanol
分子式
C6H9N3O3
分子量
171.15 g/mol
精确质量
171.06439116 Da
单同位素质量
171.06439116 Da
XLogP3
0.0
拓扑极性表面积
83.9 Ų
分子复杂度
170.0
形式电荷
0
氢键供体
1
氢键受体
4
可旋转键
2
重原子
12
共价单元
1

向 PubChem 报告的名称和同义词

MetronidazolGineflavir2-Methyl-5-nitroimidazole-1-ethanolDeflamonOrvagilTrichazolMetroGelSanatrichom
另有 16 个已报告名称
AnagiardilDanizolMeronidalMetronidazMexibolTrichocideTricocetTrivazolVagilenVagimidArilinClontKlionBayer 5360MetronidazoloAcromona
外部数据库标识符
高级结构统计
已定义的原子立体中心
0
未定义的原子立体中心
0
已定义的键立体中心
0
未定义的键立体中心
0
三维药效团特征
7
三维环
1
三维疏水基团
0
三维受体特征
3
三维供体特征
1
三维阴离子中心
1
三维阳离子中心
1
三维构象异构体
2
有效三维可旋转键
3.0
机器可读的结构标识符
SMILES
CC1=NC=C(N1CCO)[N+](=O)[O-]
InChI
InChI=1S/C6H9N3O3/c1-5-7-4-6(9(11)12)8(5)2-3-10/h4,10H,2-3H2,1H3
InChIKey
VAOCPAMSLUNLGC-UHFFFAOYSA-N

于 2026-08-31 通过校验和有效的 CAS 匹配从美国国立卫生研究院 (NIH) PubChem 检索。化学性质不能取代本页的监管决定。

CAS 536-33-4 的 PubChem 二维化学结构
CAS 536-33-4PubChem CID 2761171

CAS 536-33-4 的已核实化学信息

Ethionamide

Ethionamide is a thiocarboxamide that is pyridine-4-carbothioamide substituted by an ethyl group at position 2. A prodrug that undergoes metabolic activation by conversion to the corresponding S-oxide. It has a role as an antitubercular agent, an antilipemic drug, a leprostatic drug, a fatty acid synthesis inhibitor and a prodrug. It is a member of pyridines and a thiocarboxamide. — ChEBI

IUPAC 名称
2-ethylpyridine-4-carbothioamide
分子式
C8H10N2S
分子量
166.25 g/mol
精确质量
166.05646950 Da
单同位素质量
166.05646950 Da
XLogP3
1.1
拓扑极性表面积
71.0 Ų
分子复杂度
147.0
形式电荷
0
氢键供体
1
氢键受体
2
可旋转键
2
重原子
11
共价单元
1

向 PubChem 报告的名称和同义词

TrecatorEthioniamideAmidazineEthinamideEthyonomideEtionamidEtioniamid2-Ethylthioisonicotinamide
另有 16 个已报告名称
NizotinEthylisothiamideTeberusTrecator-SCAmidazinBayer 5312IridocinIridozinSertinonThianideTrescatylEtionid4-Pyridinecarbothioamide, 2-ethyl-EtionizinEtionizineEthimide
外部数据库标识符
高级结构统计
已定义的原子立体中心
0
未定义的原子立体中心
0
已定义的键立体中心
0
未定义的键立体中心
0
三维药效团特征
4
三维环
1
三维疏水基团
1
三维受体特征
2
三维供体特征
0
三维阴离子中心
0
三维阳离子中心
0
三维构象异构体
10
有效三维可旋转键
2.0
机器可读的结构标识符
SMILES
CCC1=NC=CC(=C1)C(=S)N
InChI
InChI=1S/C8H10N2S/c1-2-7-5-6(8(9)11)3-4-10-7/h3-5H,2H2,1H3,(H2,9,11)
InChIKey
AEOCXXJPGCBFJA-UHFFFAOYSA-N

于 2026-08-31 通过校验和有效的 CAS 匹配从美国国立卫生研究院 (NIH) PubChem 检索。化学性质不能取代本页的监管决定。

CAS 60-56-0 的 PubChem 二维化学结构
CAS 60-56-0PubChem CID 1349907

CAS 60-56-0 的已核实化学信息

Methimazole

Methimazole is a member of the class of imidazoles that it imidazole-2-thione in which a methyl group replaces the hydrogen which is attached to a nitrogen. It has a role as an antithyroid drug. — ChEBI

IUPAC 名称
3-methyl-1H-imidazole-2-thione
分子式
C4H6N2S
分子量
114.17 g/mol
精确质量
114.02516937 Da
单同位素质量
114.02516937 Da
XLogP3
-0.3
拓扑极性表面积
47.4 Ų
分子复杂度
119.0
形式电荷
0
氢键供体
1
氢键受体
1
可旋转键
0
重原子
7
共价单元
1

向 PubChem 报告的名称和同义词

thiamazoleTapazole1-Methyl-1H-imidazole-2-thiolMethimazol1-Methylimidazole-2-thiolMercazolylThiamazolMercazole
另有 16 个已报告名称
ThymidazolThymidazoleFavistanMercaptazoleMetothyrineMetazoloMetothyrinStrumazolThycapzolDanantizolFrentiroxMerkazolilMetotirinThacapzolBasolanMercasolyl
外部数据库标识符
高级结构统计
已定义的原子立体中心
0
未定义的原子立体中心
0
已定义的键立体中心
0
未定义的键立体中心
0
三维药效团特征
3
三维环
1
三维疏水基团
0
三维受体特征
1
三维供体特征
1
三维阴离子中心
0
三维阳离子中心
0
三维构象异构体
1
有效三维可旋转键
0.0
机器可读的结构标识符
SMILES
CN1C=CNC1=S
InChI
InChI=1S/C4H6N2S/c1-6-3-2-5-4(6)7/h2-3H,1H3,(H,5,7)
InChIKey
PMRYVIKBURPHAH-UHFFFAOYSA-N

于 2026-08-31 通过校验和有效的 CAS 匹配从美国国立卫生研究院 (NIH) PubChem 检索。化学性质不能取代本页的监管决定。

CAS 65277-42-1 的 PubChem 二维化学结构
CAS 65277-42-1PubChem CID 47576

CAS 65277-42-1 的已核实化学信息

Ketoconazole

(2S,4R)-ketoconazole is a cis-1-acetyl-4-(4-{[2-(2,4-dichlorophenyl)-2-(1H-imidazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy}phenyl)piperazine which dioxolane moiety has (2S,4R)-configuration. It is an enantiomer of a (2R,4S)-ketoconazole. — ChEBI

IUPAC 名称
1-[4-[4-[[(2S,4R)-2-(2,4-dichlorophenyl)-2-(imidazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy]phenyl]piperazin-1-yl]ethanone
分子式
C26H28Cl2N4O4
分子量
531.4 g/mol
精确质量
530.1487608 Da
单同位素质量
530.1487608 Da
XLogP3
4.3
拓扑极性表面积
69.1 Ų
分子复杂度
735.0
形式电荷
0
氢键供体
0
氢键受体
6
可旋转键
7
重原子
36
共价单元
1

向 PubChem 报告的名称和同义词

NizoralPanfungolKetodermFungarestFungoralKetoisdinKetozoleExtina
另有 16 个已报告名称
Orifungal MNizoral a-DKetoconazolXolegelKetoconazolumPiperazine, 1-acetyl-4-[4-[[2-(2,4-dichlorophenyl)-2-(1H-imidazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy]phenyl]-, cis-R 41400R9400W927ICHEBI:47519Piperazine, 1-acetyl-4-(4-((2-(2,4-dichlorophenyl)-2-(1H-imidazol-1-ylmethyl)-1,3-dioxolan-4-yl)methoxy)phenyl)-, cis-R-41400DandrazolDandridKetopineNizorelle(+-)-cis-1-Acetyl-4-(p-((2-(2,4-dichlorophenyl)-2-(imidazol-1-ylmethyl)-1,3-dioxolan-4-yl)methoxy)phenyl)piperazine
外部数据库标识符
高级结构统计
已定义的原子立体中心
2
未定义的原子立体中心
0
已定义的键立体中心
0
未定义的键立体中心
0
三维药效团特征
11
三维环
5
三维疏水基团
0
三维受体特征
4
三维供体特征
0
三维阴离子中心
0
三维阳离子中心
2
三维构象异构体
10
有效三维可旋转键
10.2
机器可读的结构标识符
SMILES
CC(=O)N1CCN(CC1)C2=CC=C(C=C2)OC[C@@H]3CO[C@@](O3)(CN4C=CN=C4)C5=C(C=C(C=C5)Cl)Cl
InChI
InChI=1S/C26H28Cl2N4O4/c1-19(33)31-10-12-32(13-11-31)21-3-5-22(6-4-21)34-15-23-16-35-26(36-23,17-30-9-8-29-18-30)24-7-2-20(27)14-25(24)28/h2-9,14,18,23H,10-13,15-17H2,1H3/t23-,26-/m1/s1
InChIKey
XMAYWYJOQHXEEK-ZEQKJWHPSA-N

于 2026-08-31 通过校验和有效的 CAS 匹配从美国国立卫生研究院 (NIH) PubChem 检索。化学性质不能取代本页的监管决定。

CAS 67-20-9 的 PubChem 二维化学结构
CAS 67-20-9PubChem CID 6604200

CAS 67-20-9 的已核实化学信息

Nitrofurantoin

Nitrofurantoin is an imidazolidine-2,4-dione that is hydantoin substituted at position 1 by a [(5-nitro-2-furyl)methylene]amino group. An antibiotic that damages bacterial DNA. It has a role as an antiinfective agent, an antibacterial drug and a hepatotoxic agent. It is an imidazolidine-2,4-dione, an organonitrogen heterocyclic antibiotic, an organooxygen heterocyclic antibiotic and a nitrofuran antibiotic. It is functionally related to a semicarbazide. — ChEBI

IUPAC 名称
1-[(E)-(5-nitrofuran-2-yl)methylideneamino]imidazolidine-2,4-dione
分子式
C8H6N4O5
分子量
238.16 g/mol
精确质量
238.03381930 Da
单同位素质量
238.03381930 Da
XLogP3
-0.5
拓扑极性表面积
121.0 Ų
分子复杂度
390.0
形式电荷
0
氢键供体
1
氢键受体
6
可旋转键
2
重原子
17
共价单元
1

向 PubChem 报告的名称和同义词

FuradantinMacrodantin5-NitrofurantoinFuradantoinFuradoninFuradontinNifurantinFuralan
另有 16 个已报告名称
MacrobidOrafuranParfuranUrantoinIturanNitrofurantoinaNitrofurantoineBerkfurinChemiofuranFurachelFuradoineFuradonineFuratoinFurobactinaNovofuranTrantoin
外部数据库标识符
高级结构统计
已定义的原子立体中心
0
未定义的原子立体中心
0
已定义的键立体中心
1
未定义的键立体中心
0
三维药效团特征
10
三维环
2
三维疏水基团
0
三维受体特征
6
三维供体特征
1
三维阴离子中心
1
三维阳离子中心
0
三维构象异构体
10
有效三维可旋转键
3.6
机器可读的结构标识符
SMILES
C1C(=O)NC(=O)N1/N=C/C2=CC=C(O2)[N+](=O)[O-]
InChI
InChI=1S/C8H6N4O5/c13-6-4-11(8(14)10-6)9-3-5-1-2-7(17-5)12(15)16/h1-3H,4H2,(H,10,13,14)/b9-3+
InChIKey
NXFQHRVNIOXGAQ-YCRREMRBSA-N

于 2026-08-31 通过校验和有效的 CAS 匹配从美国国立卫生研究院 (NIH) PubChem 检索。化学性质不能取代本页的监管决定。

CAS 67-45-8 的 PubChem 二维化学结构
CAS 67-45-8PubChem CID 5323714

CAS 67-45-8 的已核实化学信息

Furazolidone

Furazolidone is a member of the class of oxazolidines that is 1,3-oxazolidin-2-one in which the hydrogen attached to the nitrogen is replaced by an N-{[(5-nitro-2-furyl)methylene]amino} group. It has antibacterial and antiprotozoal properties, and is used in the treatment of giardiasis and cholera. It has a role as an antiinfective agent, an antibacterial drug, an EC 1.4.3.4 (monoamine oxidase) inhibitor and an antitrichomonal drug. It is a member of oxazolidines and a nitrofuran antibiotic. — ChEBI

IUPAC 名称
3-[(E)-(5-nitrofuran-2-yl)methylideneamino]-1,3-oxazolidin-2-one
分子式
C8H7N3O5
分子量
225.16 g/mol
精确质量
225.03857033 Da
单同位素质量
225.03857033 Da
XLogP3
-0.1
拓扑极性表面积
101.0 Ų
分子复杂度
326.0
形式电荷
0
氢键供体
0
氢键受体
6
可旋转键
2
重原子
16
共价单元
1

向 PubChem 报告的名称和同义词

FuroxoneNitrofurazolidoneFurazolidineNitrofuroxonDiafuronFurazolFuridonNeftin
另有 16 个已报告名称
FuraxoneFurazolidonFuroxaneNifulidoneFurazonFuroxonGiarlamNitrofurazolidonumFurozolidineNifurazolidoneTikofuranTrichofuronTricofuronCoryziumFuraxonFuroxal
外部数据库标识符
高级结构统计
已定义的原子立体中心
0
未定义的原子立体中心
0
已定义的键立体中心
1
未定义的键立体中心
0
三维药效团特征
8
三维环
2
三维疏水基团
0
三维受体特征
5
三维供体特征
0
三维阴离子中心
1
三维阳离子中心
0
三维构象异构体
6
有效三维可旋转键
3.8
机器可读的结构标识符
SMILES
C1COC(=O)N1/N=C/C2=CC=C(O2)[N+](=O)[O-]
InChI
InChI=1S/C8H7N3O5/c12-8-10(3-4-15-8)9-5-6-1-2-7(16-6)11(13)14/h1-2,5H,3-4H2/b9-5+
InChIKey
PLHJDBGFXBMTGZ-WEVVVXLNSA-N

于 2026-08-31 通过校验和有效的 CAS 匹配从美国国立卫生研究院 (NIH) PubChem 检索。化学性质不能取代本页的监管决定。

CAS 67-96-9 的 PubChem 二维化学结构
CAS 67-96-9PubChem CID 5311071

CAS 67-96-9 的已核实化学信息

Dihydrotachysterol

Dihydrotachysterol is a hydroxy seco-steroid that is 9,10-secoergosta-5,7,22-triene substituted by a hydroxy group at position 3. A synthetic analogue of vitamin D that acts a bone density conservation agent. It has a role as a bone density conservation agent. It is a vitamin D, a seco-ergostane and a hydroxy seco-steroid. — ChEBI

IUPAC 名称
trans-(1S,3E,4S)-3-[(2E)-2-[(1R,3aS,7aR)-1-[(E,2R,5R)-5,6-dimethylhept-3-en-2-yl]-7a-methyl-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]ethylidene]-4-methylcyclohexan-1-ol
分子式
C28H46O
分子量
398.7 g/mol
精确质量
398.354866087 Da
单同位素质量
398.354866087 Da
XLogP3
7.7
拓扑极性表面积
20.2 Ų
分子复杂度
639.0
形式电荷
0
氢键供体
1
氢键受体
1
可旋转键
5
重原子
29
共价单元
1

向 PubChem 报告的名称和同义词

DichystrolumAntitanilHytakerolTachystinDihidrotaquisterolDihydrotachysterol2DihydralDygratyl
另有 16 个已报告名称
ParterolTachyrolAnti-tetany substance 10DihydrotachysterolumDHT2DiidrotachisteroloDihydrotachysterol 2AT 10Tachysterol, dihydro-Tachysterol2, dihydro-A.T. 10R5LM3H112RTachysterol dihydro derivativeCHEBI:45919,10-Secoergosta-5,7,22-trien-3beta-ol(1S,3E,4S)-3-{2-[(1R,3aS,4E,7aR)-1-[(2R,3E,5R)-5,6-dimethylhept-3-en-2-yl]-7a-methyl-octahydro-1H-inden-4-ylidene]ethylidene}-4-methylcyclohexan-1-ol
外部数据库标识符
高级结构统计
已定义的原子立体中心
7
未定义的原子立体中心
0
已定义的键立体中心
3
未定义的键立体中心
0
三维药效团特征
8
三维环
3
三维疏水基团
3
三维受体特征
1
三维供体特征
1
三维阴离子中心
0
三维阳离子中心
0
三维构象异构体
10
有效三维可旋转键
7.2
机器可读的结构标识符
SMILES
C[C@H]\1CC[C@@H](C/C1=C\C=C\2/CCC[C@]3([C@H]2CC[C@@H]3[C@H](C)/C=C/[C@H](C)C(C)C)C)O
InChI
InChI=1S/C28H46O/c1-19(2)20(3)9-10-22(5)26-15-16-27-23(8-7-17-28(26,27)6)12-13-24-18-25(29)14-11-21(24)4/h9-10,12-13,19-22,25-27,29H,7-8,11,14-18H2,1-6H3/b10-9+,23-12+,24-13+/t20-,21-,22+,25-,26+,27-,28+/m0/s1
InChIKey
ILYCWAKSDCYMBB-OPCMSESCSA-N

于 2026-08-31 通过校验和有效的 CAS 匹配从美国国立卫生研究院 (NIH) PubChem 检索。化学性质不能取代本页的监管决定。

CAS 87-10-5 的 PubChem 二维化学结构
CAS 87-10-5PubChem CID 14868

CAS 87-10-5 的已核实化学信息

3,4',5-Tribromosalicylanilide

Tribromosalicylanilide is a salicylanilide derivative with bromo- substituents at C-3 and C-5 of the salicylate moiety and at C-4 of the anilide moiety. It is functionally related to a salicylanilide. — ChEBI

IUPAC 名称
3,5-dibromo-N-(4-bromophenyl)-2-hydroxybenzamide
分子式
C13H8Br3NO2
分子量
449.92 g/mol
精确质量
448.80847 Da
单同位素质量
446.81052 Da
XLogP3
5.0
拓扑极性表面积
49.3 Ų
分子复杂度
321.0
形式电荷
0
氢键供体
2
氢键受体
2
可旋转键
2
重原子
19
共价单元
1

向 PubChem 报告的名称和同义词

TribromsalanTemasept IVTrisanilTuasol 100ET-394NSC-205266MCE3VTF0OSalicylanilide, 3,4',5-tribromo-
另有 16 个已报告名称
BENZAMIDE, 3,5-DIBROMO-N-(4-BROMOPHENYL)-2-HYDROXY-WR-34912CHEBI:127105DiapheneTemaceptRefChem:899088201-723-63,5,4'-TribromosalicylanilideAgramedTRIBROMOSALICYLANILIDETemasept IITrisanylTempasept IISherstat TBSVancide TBSTribromsalanum
外部数据库标识符
高级结构统计
已定义的原子立体中心
0
未定义的原子立体中心
0
已定义的键立体中心
0
未定义的键立体中心
0
三维药效团特征
8
三维环
2
三维疏水基团
3
三维受体特征
1
三维供体特征
2
三维阴离子中心
0
三维阳离子中心
0
三维构象异构体
5
有效三维可旋转键
3.0
机器可读的结构标识符
SMILES
C1=CC(=CC=C1NC(=O)C2=C(C(=CC(=C2)Br)Br)O)Br
InChI
InChI=1S/C13H8Br3NO2/c14-7-1-3-9(4-2-7)17-13(19)10-5-8(15)6-11(16)12(10)18/h1-6,18H,(H,17,19)
InChIKey
KVSKGMLNBAPGKH-UHFFFAOYSA-N

于 2026-09-02 通过校验和有效的 CAS 匹配从美国国立卫生研究院 (NIH) PubChem 检索。化学性质不能取代本页的监管决定。

官方来源与出处

已登记来源
China NMPA banned raw-material catalogues (2021)
来源参考
NMPA 2021 Catalogue of Raw Materials Banned for Cosmetics, entry 299
来源记录 ID
chemical-299
来源版本
NMPA Announcement No. 74 of 2021, effective 2021-05-26
来源语言
Chinese with source English/Latin identity
翻译状态
Official English translation · 英文译文
生效日期
2021-05-26
来源更新
2021-05-26
快照检查时间
2026-08-31 14:13 UTC
验证方法
pdfplumber tables; exact 1,284 + 109 row counts and contiguous source numbering
SHA-256
8848aa3e0c7ac5e74f56fc27927336c4fc2e5bc80137da087c2ca9ba2d2c075e

已登记的数据集备注

数据集覆盖范围
All 1,284 banned raw materials and 109 banned plant/animal raw materials effective from 26 May 2021
权威性说明
Binding NMPA catalogues replacing Tables 1 and 2 of the 2015 Technical Specification

本记录在市场数据集中的位置

1393
条当前 China 记录
1393
条标记为 Prohibited 的记录
1393
条来自此来源版本的记录
1249
条带有 CAS 身份的市场记录

状态分布

在 1393 条当前记录中,有 1393 条带有条件文本。条件字段为空时,按上述记录类型解释;绝不会被转换为可无限制使用的声明。

China 市场背景

Complete prohibited catalogues plus official-source workflow

覆盖版本: NMPA 2021 banned catalogues plus dynamic IECIC List I/List II system current since 2025

All 1,284 banned raw materials and 109 banned plant/animal raw materials, plus the official workflow for the dynamic existing-ingredient inventory, other technical restrictions and new ingredients.

核实清单

  1. Search the current NMPA IECIC List I and List II by Chinese name and identity.
  2. Check prohibited/restricted and positive lists in the current Safety and Technical Standards.
  3. Review technical purpose, use history and any monitoring period.
  4. Confirm Chinese labelling, safety assessment and filing/registration duties.

官方市场来源

核实工作流程与记录完整性

在将此结果用于合规决定之前

  1. 确认“抗感染类药物,包括但不限于三溴沙 仑、抗生素类、二氢速甾醇、乙硫异烟 胺、呋喃唑酮、酮康唑、甲硝唑、呋喃 妥因、磺胺类药物(磺胺和其氨基的一 个或多个氢原子被取代的衍生物)及其 盐类、甲巯咪唑、短杆菌素等 — Anti-infectives, including but not limited to 3,4',5-Tribromosalicylanilide (Tribromsalan (INN) )(CAS No. 87-10-5), Antibiotics, Dihydrotachysterol (INN) (CAS No. 67-96-9), Ethionamide (INN) (CAS No. 536-33-4), Furazolidone (INN) (CAS No. 67-45-8), Ketoconazole (CAS No. 65277-42-1), Metronidazole (CAS No. 443-48-1), Nitrofurantoin (INN) (CAS No. 67-20-9), Sulphonamides (sulphanilamide and its derivatives obtained by substitution of one or more H-atoms of the -NH2 groups) and their salts, Thiamazole (INN) (CAS No. 60-56-0), Thyrothricine (CAS No. 1404-88-2)”及每个 CAS/EC 标识符所指的物料与您的供应商规格一致。
  2. Search the current NMPA IECIC List I and List II by Chinese name and identity.
  3. Check prohibited/restricted and positive lists in the current Safety and Technical Standards.
  4. Review technical purpose, use history and any monitoring period.
  5. Confirm Chinese labelling, safety assessment and filing/registration duties.
  6. 记录来源版本,并在生产、备案或上市之前重新核查监管机构。

本记录中的可用字段

  • 官方物质名称可用
  • CAS可用
  • EC未提供
  • 单独的条件文本可用
  • 生效日期可用
  • 快照哈希与方法可用

本页回答的问题

This official record identifies the substance as prohibited for cosmetic use in the stated market scope. Do not rely on a formulation containing this identity until the cited source, effective date and exact substance match have been verified.

A prohibition entry may contain no separate condition text because the regulatory outcome is the prohibition itself. IECIC listing is not blanket approval; absence may require the new cosmetic ingredient route, and restrictions are checked separately.

该记录引用 NMPA 2021 Catalogue of Raw Materials Banned for Cosmetics, entry 299,来源版本 NMPA Announcement No. 74 of 2021, effective 2021-05-26。 打开官方来源。

不保证。CAS 有助于确定身份,但各辖区可能对同一物质作出不同分类,并可能适用不同的产品范围、限值、警示语和过渡日期。

稳定引用

抗感染类药物,包括但不限于三溴沙 仑、抗生素类、二氢速甾醇、乙硫异烟 胺、呋喃唑酮、酮康唑、甲硝唑、呋喃 妥因、磺胺类药物(磺胺和其氨基的一 个或多个氢原子被取代的衍生物)及其 盐类、甲巯咪唑、短杆菌素等 — Anti-infectives, including but not limited to 3,4',5-Tribromosalicylanilide (Tribromsalan (INN) )(CAS No. 87-10-5), Antibiotics, Dihydrotachysterol (INN) (CAS No. 67-96-9), Ethionamide (INN) (CAS No. 536-33-4), Furazolidone (INN) (CAS No. 67-45-8), Ketoconazole (CAS No. 65277-42-1), Metronidazole (CAS No. 443-48-1), Nitrofurantoin (INN) (CAS No. 67-20-9), Sulphonamides (sulphanilamide and its derivatives obtained by substitution of one or more H-atoms of the -NH2 groups) and their salts, Thiamazole (INN) (CAS No. 60-56-0), Thyrothricine (CAS No. 1404-88-2). NMPA 2021 Catalogue of Raw Materials Banned for Cosmetics, entry 299. China. Source version NMPA Announcement No. 74 of 2021, effective 2021-05-26. CosIng Checker regulatory record: https://cosingchecker.com/zh-hans/regulations/cn/records/11988/

请将监管机构作为法律依据来引用。本页是结构化的证据索引和核实辅助工具,不能替代官方文本或专业法律评估。

China 的解读与局限

This official record identifies the substance as prohibited for cosmetic use in the stated market scope.

Do not rely on a formulation containing this identity until the cited source, effective date and exact substance match have been verified.

如何解读法律地位

The cited row forms part of a binding rule or legally incorporated list for this market.

本页证据

  • 记录结果:Prohibited
  • 法律地位:Binding rule
  • 来源版本:NMPA Announcement No. 74 of 2021, effective 2021-05-26
  • 生效日期:2021-05-26

它不能证明什么

IECIC listing is not blanket approval; absence may require the new cosmetic ingredient route, and restrictions are checked separately.

进一步的权威物质研究

这些来源均不能推翻上述市场决定。

Cosmetic Ingredient Review safety assessments

Expert Panel conclusions, assessed ingredient groups, use conditions, dates and report documents

Independent expert review considered by FDA; not a government approval or binding market rule

在来源处研究此身份

FDA Global Substance Registration System

UNII identifiers, preferred names, substance types, codes and public substance relationships

Identity registry only; UNII availability does not imply FDA review or approval

在来源处研究此身份

ILO/WHO International Chemical Safety Cards

Hazards, symptoms, first aid, storage, incompatibilities and physical properties for covered chemicals

International occupational chemical-safety reference; not cosmetic-use approval

在来源处研究此身份

Japan NITE-CHRIP

Chemical identity, Japanese and foreign legal lists, GHS hazards and exposure-related information

Chemical-management evidence; cosmetic status remains governed by the applicable MHLW standard and market rules

在来源处研究此身份

NIOSH Pocket Guide to Chemical Hazards

REL, PEL, IDLH, properties, exposure routes, symptoms, target organs, first aid and measurement methods for covered workplace chemicals

US occupational-health guidance and limits; not a cosmetic ingredient decision

在来源处研究此身份

OECD eChemPortal

Gateway to authority-owned physical-property, fate, ecotoxicity, toxicity, exposure and GHS records

Discovery gateway; each linked authority remains responsible for its data

在来源处研究此身份

US EPA CompTox CTX APIs

导入需要 API 密钥

DTXSID identity, experimental and predicted properties, toxicity, bioactivity, exposure and environmental data

Scientific and computational evidence; predictions must remain labelled and do not determine cosmetic legality

在来源处研究此身份